THE MILLION WOMEN STUDY

Rejuvime Medical • October 7, 2015

The Million Women Study was conducted by The University of Oxford with the goal of recruiting women in the UK to answer the following questions:

What effects do combined oestrogen and progestagen hormone replacement therapy (HRT) preparations have on breast cancer risk?

Are breast cancers detected at screening in women who have used HRT or oral contraceptives different in terms of size and invasiveness from the cancers detected in women who have never used these hormones?

How does HRT use affect the efficacy of breast cancer screening?

How does HRT use affect mortality from breast cancer and other conditions?

Visit the link below to view the current progress of this study:

 

Newer Post >

Get in Touch

Questions? Contact us today by phone or book an appointment online.

Questions? Call our office:

(225) 228-3128

GLP-1 therapy may impact cognitive function

GLP-1 Medications and Brain Health: Can They Improve Memory and Cognitive Function?

By Rejuvime Medical • February 26, 2026
GLP-1 medications may do more than support weight loss. Learn how GLP-1 therapy and metabolic health may play a role in protecting memory and cognitive function.
Oral GLP for weight loss

Oral GLP-1 Medications: Do They Really Work for Weight Loss?

By Rejuvime Medical • February 26, 2026
Do oral GLP-1 medications really work for weight loss? Learn how oral GLP-1s compare to injections, what results to expect, and how Rejuvime Medical personalizes GLP-1 therapy for sustainable fat loss.
Pellet therapy for hormone optimization

Pellet Therapy for Hormone Optimization: Who Is a Good Candidate?

By Rejuvime Medical • February 20, 2026
Considering hormone pellet therapy? Learn how bioidentical hormone pellets work, who qualifies, and whether this long-lasting HRT option fits your health goals.
Show More